Showing results (1891-1900 of 2,263) with videos related to

Sort By:
Pageof 227
Epilepsy & Behavior : E&B|December 23, 2014
Features of autism spectrum disorder (ASD) in childhood epilepsy: a population-based studyColin Reilly, Patricia Atkinson, Krishna B Das, et al.
Journal of Pediatric Orthopedics|January 13, 2018
Orthopaedic Management of Leg-length Discrepancy in Proteus Syndrome: A Case SeriesMolly M Crenshaw, Cara G Goerlich, Lauren E Ivey, et al.
The Journal of Heredity|September 23, 2022
mtDNA heteroplasmy gives rise to a new maternal lineage in North Pacific humpback whales (Megaptera novaeangliae)Sophie P Pierszalowski, Debbie J Steel, Christine M Gabriele, et al.
Clinical Rheumatology|March 7, 2023
Exploring the longer-term impact of the COVID-19 pandemic on physical and mental health of people with inflammatory rheumatic diseases: a cross-sectional surveySamantha Hider, Sara Muller, Lauren Gray, et al.
Rheumatology Advances in Practice|March 31, 2026
Variation in the feasibility and acceptability of electronic patient-reported outcome measures in patients with inflammatory arthritisNatasha Cox, Chelsea Kettle, Haoboo Wang, et al.
American Journal of Clinical Oncology|November 5, 1997
Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06R Komaki, C Scott, J S Lee, et al.
Nature|July 27, 2004
Evolutionary genetics: Ambiguous role of CCR5 in Y. pestis infectionStephen J Elvin, E Diane Williamson, Joanne C Scott, et al.
Nature Communications|September 3, 2022
Observation of formation and local structures of metal-organic layers via complementary electron microscopy techniquesXinxing Peng, Philipp M Pelz, Qiubo Zhang, et al.
Preventing Chronic Disease|September 15, 2022
Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection ProgramYamisha Bermudez, Lia C Scott, Michele Beckman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1993
Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302D F Nelson, W J Curran, C Scott, et al.
Pageof 227